Attorney General Jason Miyares announced the final approval of opioid agreements with drug makers Teva and Allergan and pharmacies CVS and Walgreens. Virginia will receive up to approximately $365.6 million over 15 years, which is expected to start being paid by the end of 2023. According to the AG’s office Virginia’s share of national investigations and litigation against the pharmaceutical industry over the opioid crisis so far is nearly $1 billion.